BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,288 | +44.1% | 423,733 | +56.0% | 0.01% | +71.4% |
Q2 2023 | $894 | +20.8% | 271,627 | +154.0% | 0.01% | -36.4% |
Q4 2022 | $740 | -100.0% | 106,923 | -56.0% | 0.01% | -45.0% |
Q3 2022 | $1,539,000 | +115.2% | 243,095 | +40.7% | 0.02% | +122.2% |
Q2 2022 | $715,000 | +114.1% | 172,759 | +150.7% | 0.01% | +125.0% |
Q1 2022 | $334,000 | -78.7% | 68,909 | -16.1% | 0.00% | -81.0% |
Q3 2021 | $1,570,000 | +259.3% | 82,133 | +913.7% | 0.02% | +133.3% |
Q3 2020 | $437,000 | -68.3% | 8,102 | -64.1% | 0.01% | -75.0% |
Q2 2020 | $1,379,000 | +241.3% | 22,585 | +413.3% | 0.04% | +157.1% |
Q3 2019 | $404,000 | -13.9% | 4,400 | +19.4% | 0.01% | -26.3% |
Q2 2019 | $469,000 | – | 3,686 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |